Fei Liu

机构：Yidu Central Hospital of Weifang, Shanghai East Hospital · ORCID：0000-0003-3684-0944

发表论文 27 篇 · 总被引 525 次 · h-index 14

代表论文

• Efficacy and Safety of Ivarmacitinib in Patients With Moderate-to-Severe, Active, Ulcerative Colitis: A Phase II Study (2022 · Gastroenterology · 被引 51)
• Integrative Effects and Vagal Mechanisms of Transcutaneous Electrical Acustimulation on Gastroesophageal Motility in Patients With Gastroesophageal Reflux Disease (2021 · The American Journal of Gastroenterology · 被引 47)
• Probiotics as an adjuvant treatment in Helicobacter pylori eradication therapy (2017 · Journal of Digestive Diseases · 被引 46)
• H + /K + -ATPase inhibitors: a patent review (2012 · Expert Opinion on Therapeutic Patents · 被引 41)
• Comparison of vonoprazan-based with rabeprazole-based dual therapy for treatment-naive patients of Helicobacter pylori infection: a prospective, multi-center, randomized controlled study (2023 · Journal of Gastroenterology · 被引 38)
• Infliximab Preferentially Induces Clinical Remission and Mucosal Healing in Short Course Crohn’s Disease with Luminal Lesions through Balancing Abnormal Immune Response in Gut Mucosa (2015 · Mediators of Inflammation · 被引 34)